SFSongtao Feng

Songtao Feng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Songtao Feng has a total of 69 co-authors. Here are the top co-authors by number of shared publications:

  • Bi-Cheng Liu

    Institute of Nephrology, Zhongda Hospital, Southeast University School of Medicine, Nanjing, Jiangsu, China

    3 shared publications
  • Bin Wang

    Institute of Nephrology, Zhongda Hospital, Southeast University School of Medicine, Nanjing, China

    2 shared publications
  • Bing Song

    Department of Endocrinology, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China

    2 shared publications
  • Hui Zhang

    Endocrinology and Metabolism Center, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, China

    2 shared publications
  • Yi Wen

    Institute of Nephrology Zhongda Hospital, Southeast University School of Medicine Nanjing China

    2 shared publications
  • Yue-Ming Gao

    Institute of Nephrology, Zhongda Hospital, Southeast University School of Medicine, Nanjing, 210009, People’s Republic of China

    2 shared publications

Latest Publications

  • Open Access

    Association between C-reactive protein-triglyceride-glucose index and one-year all-cause mortality in patients with cardiometabolic multimorbidity

    by Zhongyuan Zhang, Chaoqun Xu, Lili Huo, Haitao He, Lanting Li, Songtao Feng, Aibin Tao

    Introduction: Cardiometabolic multimorbidity (CMM) is increasingly prevalent among middle-aged and older adults. The C-reactive protein-triglyceride glucose index (CTI), a novel biomarker integrating inflammation and insulin resistance (IR), has been linked to CMM prevalence and incidence. However, its association with all-cause mortality in CMM patients remains unclear. This study aimed to investigate the relationship between CTI and one-year mortality in CMM patients. Methods: The retrospective-prospective cohort study enrolled 7,220 participants between January 2022 and December 2024. The primary endpoint was all-cause mortality within 365 days of admission. Mortality was verified in January 2026 through electronic medical record (EMR) review and telephone follow-up, with no loss to follow-up. Patients were categorized into four groups according to the quartiles of the CTI. We employed least absolute shrinkage and selection operator (LASSO) regression to identify key predictors. Cox proportional hazards models, Kaplan–Meier curves, restricted cubic spline analyses, and ROC curves were employed to evaluate the associations of CTI with the mortality in CMM patients. Additionally, subgroup analyses were conducted to explore potential effect modifiers. Results: This study included 7,220 individuals with CMM. During the one-year follow-up, 537 (7.44%) deaths occurred, with elevated CTI levels showing a significant association with increased risks of all-cause mortality. Per 1-SD increase in CTI corresponded to a 17% higher mortality risk (HR = 1.17, 95% CI 1.07–1.29), while patients in the highest CTI quartile exhibited a 75% elevated risk vs. the lowest quartile (HR = 1.75, 95% CI 1.30–2.37). Our results suggested a positive association between CTI and CMM mortality, with risk increasing from Q1 to Q3 and plateauing in Q4. Additionally, CTI alone yielded an AUC of 0.639, the base model yielded an AUC of 0.828; the addition of CTI increased the AUC to 0.833. Conclusion: Our analysis revealed that elevated CTI levels were significantly associated with all-cause mortality in CMM patients. As a clinically practical marker, CTI may serve as an exploratory risk-stratification marker in CMM patients and its clinical utility remains to be confirmed in prospective studies.

  • Open Access

    Association of herbal tea consumption with cardiovascular diseases in the general population: evidence from the MESA cohort

    by Baowei Zhang, Wenjuan Tang, Yizhang Wu, Songtao Feng, Bing Yang

    Green tea and black tea have shown beneficial effects on cardiovascular health, and they are recommended for the prevention of cardiovascular disease (CVD) events. However, the impact of herbal tea on cardiovascular health remains unclear. This study aims to evaluate the potential benefits of herbal tea consumption in reducing the risk of incident CVD events in the general population. Data for this study were derived from the Multi-Ethnic Study of Atherosclerosis (MESA). The primary outcome was incident CVD events, while secondary outcomes included all-cause and cardiovascular mortality. Cox proportional hazards regression models were used to examine the relationship between herbal tea consumption and the risk of incident CVD events. Kaplan-Meier survival curves were employed to assess the timing of incident CVD events, all-cause mortality and cardiovascular mortality. A total of 4711 participants were included in the analysis, with 1834 (38.9%) in the herbal tea group and 2877 (61.1%) in the control group. Over a median follow-up of 14.1 years, 547 participants (11.61%) experienced new-onset CVD events. The herbal tea group had a significantly lower incidence of new-onset CVD events (9.0% vs. 13.3%, p < 0.001), all-cause mortality (5.1% vs. 8.8%, p < 0.001), and cardiovascular mortality (1.4% vs. 2.5%, p = 0.01) compared to the control group. Multivariate Cox regression analysis revealed that herbal tea consumption was independently associated with a lower risk of incident CVD events [HR 0.83, 95% CI (0.69–0.997), p = 0.046] and all-cause mortality [HR 0.76, 95% CI (0.60–0.97), p = 0.03]. Kaplan-Meier analysis confirmed that participants in the herbal tea group had a significantly lower risk of incident CVD events, as well as lower all-cause and cardiovascular mortality. Secondary analyses indicated that moderate frequency herbal tea consumption (2 cups/month to 2 cups/week) and consistent consumption were associated with the most pronounced cardiovascular benefits. This study demonstrated that herbal tea consumption was associated with a lower risk of incident CVD events, as well as reduced all-cause and cardiovascular mortality. These benefits were especially evident among individuals who consumed herbal tea at a moderate frequency and maintained consistent intake over time.


  • Open Access

    Associations between systemic inflammatory indices and the risk of renal function decline in patients with type 2 diabetes mellitus: a retrospective cohort study

    by Zhi Shang, Hai-Dong Zhang, Hui Qian, Yue-Ming Gao, Song-Tao Feng

    Aims: This study aimed to investigate the associations between three systemic inflammatory indices, including the systemic immune-inflammation index (SII), systemic inflammation response index (SIRI), and pan-immune-inflammation value (PIV), and the risk of renal function decline in patients with type 2 diabetes mellitus (T2DM).Methods: We consecutively enrolled 9,537 patients with T2DM hospitalized at Peking University Third Hospital. The systemic inflammatory indices were calculated from baseline blood routine indicators. Renal function decline was defined as an estimated glomerular filtration rate decreasing by ≥ 40% from baseline. All participants were categorized into tertiles according to the systemic inflammatory indices. Restricted cubic spline (RCS) curves, multivariable Cox proportional hazard regression models, and receiver operating characteristic (ROC) curves were used for analysis.Results: A total of 1,495 outcome events were recorded during the follow-up. The RCS analysis suggested a non-linear association of systemic inflammatory indices with the risk of renal function decline (P for nonlinear < 0.001). Using the lowest tertile as reference, multivariate Cox regression revealed that patients in the highest tertile of the three systemic inflammatory indices had a significantly higher risk of renal function decline (SII: HR=1.67, 95% CI=1.47–1.91, PPP<0.001). The ROC curves showed that the SIRI was better than other two indices at predicting renal function decline.Conclusion: A significantly positive association was shown between systemic inflammatory indices and the risk of renal function decline in T2DM patients. Among these inflammatory indices, SIRI has relatively high predictive performance for renal function decline.


  • Open Access

    Triglyceride glucose-body mass index is associated with diabetic kidney disease in type 2 diabetes mellitus patients without non-alcoholic fatty liver disease

    by Yafen Chu, Hongping Yao, Ni Lu, Yu Chang, Jumei Wang, Linlin Xu, Bing Song, Songtao Feng, Hui Zhang

    Aim: The triglyceride glucose-body mass index (TyG-BMI) is correlated not only to the onset of diabetic kidney disease (DKD) associated with nutrition (including glucose and triglyceride) metabolism but also incorporates body mass index (BMI), potentially serving as an indicator of non-alcoholic fatty liver disease (NAFLD). But, the links between TyG-BMI and DKD in individuals with and without NAFLD remains further exploration. Therefore, this present research aims to investigate the relationship between TyG-BMI and DKD in these patient groups and to evaluate its diagnostic value for DKD.Methods: A total of 425 individuals diagnosed with type 2 diabetes mellitus (T2DM) were categorized into the DKD group or the Control group. Clinical indicators were compared in these two groups, and the relationships between TyG-BMI and either the estimated glomerular filtration rate (eGFR) or the urinary albumin-to-creatinine ratio (UACR) were examined. Risk factors for DKD were examined, and the diagnostic value of TyG-BMI was assessed in patients without and with NAFLD.Results: Compared to 288 participants without DKD, 137 individuals with DKD exhibited higher TyG-BMI levels. In all individuals with T2DM, a higher TyG-BMI was recognized as a contributing factor to the development of DKD. Notably, this association was observed in patients without NAFLD, while no such link was established in those diagnosed with NAFLD. For T2DM patients lacking NAFLD, the TyG-BMI threshold of 49.2415 demonstrated a sensitivity of 91.3% and a specificity of 70.1%.Conclusion: Increased TyG-BMI values are associated with a higher risk of DKD and could act as potential indicators of DKD in individuals with T2DM.


  • Open Access

    Assessing the diagnostic utility of urinary albumin-to-creatinine ratio as a potential biomarker for diabetic peripheral neuropathy in type 2 diabetes mellitus patients

    by Hui Zhang, Shufang Yang, Hongxiao Wang, Huzaifa Fareeduddin Mohammmed Farooqui, Wenwen Zhu, Tong Niu, Zhen Zhang, Yang Chen, Ling Huang, Ya Zhang, et al.

    Background and aims Diabetic peripheral neuropathy (DPN) and diabetic nephropathy (DN) both have microcirculation dysfunction. Urinary albumin-to-creatinine ratio (UACR) is a biomarker for DN. We aimed to explore the links between DPN and UACR in patients with type 2 diabetes mellitus (T2DM). Methods A total of 195 T2DM patients were defined as Control or DPN group. Clinical parameters were compared, and the association between HbA1c (or UACR) and DPN was analyzed. Risk factors for DPN were observed, and the diagnostic values of HbA1c and UACR were assessed. Results Compared with 104 participants without DPN, 91 individuals with DPN exhibited higher HbA1c and UACR levels. In all patients, increased HbA1c and UACR were identified as risk factors for DPN in individuals with T2DM. Moreover, increased HbA1c was a risk factor for DPN in volunteers without DN, whereas elevated UACR was determined as a risk factor for DPN in participants with DN. The cut-off point for HbA1c (7.65%) in patients without DN had a sensitivity of 86.0% and specificity of 44.6%, while the cut-off point for UACR (196.081 mg/g) in patients with DN had a sensitivity of 52.9% and specificity of 76.2%. Conclusion Elevated HbA1c and UACR levels are risk factors for DPN and may serve as potential biomarkers for DPN in T2DM patients.


  • Open Access

    Clinical predictive factors and prediction models for end‐stage renal disease in Chinese patients with type 2 diabetes mellitus

    by Yueming Gao, Zhi Shang, Sheng Nie, Songtao Feng, Bin Wang, Zuolin Li, Min Wu, Yi Wen, Hong Xu, Jianping Weng, et al.


  • Open Access

    Urinary sediment CCL5 messenger RNA as a potential prognostic biomarker of diabetic nephropathy

    by Song-Tao Feng, Yang Yang, Jin-Fei Yang, Yue-Ming Gao, Jing-Yuan Cao, Zuo-Lin Li, Tao-Tao Tang, Lin-Li Lv, Bin Wang, Yi Wen, et al.

    Urinary sediment messenger RNAs (mRNAs) have been shown as novel biomarkers of kidney disease. We aimed to identify targeted urinary mRNAs in diabetic nephropathy (DN) based on bioinformatics analysis and clinical validation. Microarray studies of DN were searched in the GEO database and Nephroseq platform. Gene modules negatively correlated with estimated glomerular filtration rate (eGFR) were identified by informatics methods. Hub genes were screened within the selected modules. In validation cohorts, a quantitative polymerase chain reaction assay was used to compare the expression levels of candidate mRNAs. Patients with renal biopsy–confirmed DN were then followed up for a median time of 21 months. End-stage renal disease (ESRD) was defined as the primary endpoint. Multivariate Cox proportional hazards regression was developed to evaluate the prognostic values of candidate mRNAs. Bioinformatics analysis revealed four chemokines (CCL5, CXCL1, CXLC6 and CXCL12) as candidate mRNAs negatively correlated with eGFR, of which CCL5 and CXCL1 mRNA levels were upregulated in the urinary sediment of patients with DN. In addition, urinary sediment mRNA of CXCL1 was negatively correlated with eGFR (r = −0.2275, P = 0.0301) and CCL5 level was negatively correlated with eGFR (r = −0.4388, P < 0.0001) and positively correlated with urinary albumin:creatinine ratio (r = 0.2693, P = 0.0098); also, CCL5 and CXCL1 were upregulated in patients with severe renal interstitial fibrosis. Urinary sediment CCL5 mRNA was an independent predictor of ESRD [hazard ratio 1.350 (95% confidence interval 1.045–1.745)]. Urinary sediment CCL5 and CXCL1 mRNAs were upregulated in DN patients and associated with a decline in renal function and degree of renal interstitial fibrosis. Urinary sediment CCL5 mRNA could be used as a potential prognostic biomarker of DN.


  • Open Access

    Elevated Urinary Neutrophil Gelatinase‐Associated Lipocalin Is a Biomarker for Lupus Nephritis: A Systematic Review and Meta‐Analysis

    by Yueming Gao, Bin Wang, Jingyuan Cao, Songtao Feng, Bicheng Liu

    Objective. Lupus nephritis (LN) is a major and severe complication of systemic lupus erythematosus (SLE). Neutrophil gelatinase‐associated lipocalin (NGAL), as a promising next‐generation biomarker in clinical nephrology, has received extensive attention. However, its diagnostic performance in LN has high variability. Therefore, we performed an updated meta‐analysis to further evaluate the diagnostic accuracy of urinary NGAL (uNGAL). Materials and Methods. PubMed, Embase, and Cochrane Library were searched from inception to October 27, 2019. Meta‐analysis was performed with a bivariate random effects model. Additionally, the summary receiver operating characteristic (SROC) curves were established. The sources of heterogeneity were explored by meta‐regression, subgroup analysis, and sensitivity analysis. Publication bias was assessed using the Deeks test. Results. 19 articles consisting of 21 eligible studies were included. In diagnosing LN, the estimates (95% confidence interval (CI)) were as follows: sensitivity, 0.84 (0.71‐0.91); specificity, 0.91 (0.70‐0.98); and the SROC‐AUC value, 0.92 (0.90‐0.94). In identifying active LN, the estimates were as follows: sensitivity, 0.72 (0.56‐0.84); specificity, 0.71 (0.51‐0.84); and the AUC value, 0.77 (0.74‐0.81). With respect to predicting renal flare, the estimates were as follows: sensitivity, 0.80 (0.57‐0.92); specificity, 0.67 (0.58‐0.75); and the AUC value, 0.74 (0.70‐0.78). For the studies to distinguish proliferative LN, the estimates were as follows: sensitivity, 0.87 (0.66‐0.97), and specificity, 0.69 (0.39‐0.91). Deeks’ funnel plot suggested that there was no significant publication bias. Conclusions. Our meta‐analysis indicates that uNGAL was a useful biomarker for diagnosis, estimation of activity, and prediction of renal flare of LN. In addition, the usefulness of uNGAL to distinguish pathological types of LN needs to be further investigated.